In an anti-GBM glomerulonephritis mouse model and IL-1β–induced MPC5 podocytes, ginsenoside Rg1 reduces inflammation and apoptosis via Nrf2 activation, an effect confirmed by the Nrf2 inhibitor ML385 (Guo et al., 2019). Here, IL1B is linked to glomerulonephritis.